Brookfield Infrastructure Partners LP vs Citius Pharmaceuticals Inc — how do they compare? Brookfield Infrastructure Partners LP trades at $39.85 (market cap $18.10B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Brookfield Infrastructure Partners LP is far larger — about 904.5× Citius Pharmaceuticals Inc's market cap, and Brookfield Infrastructure Partners LP pays a 4.62% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| BIP | CTXR | |
|---|---|---|
Market Cap | $18.10B | $20.01M |
Sector | Industrials | Health |
52-Week High | $42.62 | $1.82 |
52-Week Low | $29.81 | $0.48 |
Enterprise Value | $77.05B | $16.23M |
Dividend Yield | 4.62% | — |
Trailing returns across standard periods
Latest headlines on both assets
Brookfield Infrastructure owns and operates high-quality global assets across utilities, transport, midstream, and data sectors. It focuses on generating stable, long-term cash flows from essential infrastructure.
Read more on BIP →Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →